aex-5 Antibody

Anion-Exchange Chromatography (AEX) in Antibody Purification

AEX chromatography is a critical downstream processing step for monoclonal antibody (mAb) purification, often following Protein A affinity chromatography . Key features include:

AEX-MS for Antibody Characterization

AEX coupled with mass spectrometry (AEX-MS) is emerging for charge variant analysis, particularly for IgG4 subclass antibodies with lower isoelectric points :

• Mechanism: Separates charge variants caused by post-translational modifications (e.g., deamidation, glycosylation).

• Advantages:

  • Resolves acidic variants (e.g., Fc deamidation) without peptide mapping .

  • Enhances resolution at elevated temperatures (40–50°C) and deglycosylated conditions .

Case Study: AEX in COVID-19 Antibody Research

While not directly referencing "aex-5," AEX principles apply to monoclonal antibody development against SARS-CoV-2 variants:

• Neutralization Escape: Omicron subvariants (e.g., XBB.1.5) evade mAbs due to mutations (e.g., F456L) .

• Bivalent Vaccines: BA.5-adapted vaccines show robust antibody boosts (median anti-spike IgG: 23,756 U/mL post-vaccination) .

Analytical Challenges and Solutions

Charge Heterogeneity remains a critical quality attribute for therapeutic mAbs. AEX and cation-exchange (CEX) chromatography are complementary:

Future Directions

• IgG4 Therapeutics: AEX-MS adoption may grow with increased IgG4 mAb development .

• Process Optimization: Hybrid AEX/CEX workflows improve yield and purity for complex mAbs .